Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: A clinical review
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference66 articles.
1. Options for the treatment of patients with taxane-refractory metastatic breast cancer;Overmoyer;Clin Breast Cancer,2008
2. Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors;Stinchcombe;Cancer Chemother Pharmacol,2007
3. nab-paclitaxel: a targeted chemotherapy to improve outcomes in metastatic breast cancer;Piccart;Asia Pac J Oncol Hematol,2009
4. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005
5. Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer;Gradishar;J Clin Oncol,2009
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Semiconducting Polymer Dots Directly Stabilized with Serum Albumin: Preparation, Characterization, and Cellular Immunolabeling;ACS Applied Materials & Interfaces;2023-11-20
2. Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in Ovarian Cancer;Current Pharmaceutical Biotechnology;2023-07
3. Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma;Investigational New Drugs;2023-01-12
4. Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy;Journal of Nanomaterials;2022-09-30
5. Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer;Anticancer Research;2021-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3